Key result
COVID-19 positivity linked to ~46% higher in-hospital all-cause mortality.
Why the study?
The prognostic implications of concurrent COVID-19 in patients with acute coronary syndrome undergoing percutaneous coronary intervention remained to be determined in large nationwide cohorts.
Does concomitant COVID-19 infection increase in-hospital mortality in patients with acute coronary syndrome undergoing emergent percutaneous coronary intervention?
Cohort (n=279,662)
Yes
Does concomitant COVID-19 infection increase in-hospital mortality in patients with acute coronary syndrome undergoing emergent percutaneous coronary intervention?
Concomitant COVID-19 infection in patients undergoing emergent PCI for ACS is independently associated with a 46% increased risk of in-hospital all-cause mortality.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
May warrant heightened vigilance in COVID-19 positive patients undergoing emergent PCI for ACS; extends observational evidence of independent mortality association.
Background: Although the COVID-19 pandemic has impacted the management of acute coronary syndrome (ACS), the prognostic implications for ACS patients with concurrent COVID-19 undergoing percutaneous coronary intervention (PCI) remain to be determined, particularly in large nationwide cohorts. This study investigated the association between concomitant COVID-19 and clinical outcomes in patients undergoing emergent PCI for ACS.
Kanaji et al. (2026) conducted a cohort in Acute coronary syndrome (n=279,662). COVID-19 positivity vs. Patients without COVID-19 was evaluated on In-hospital all-cause mortality (aOR 1.46, 95% CI 1.21–1.77, p=<0.001). COVID-19 positivity increased in-hospital all-cause mortality by 7.23% compared to 4.30% in non-COVID-19 patients, with an aOR of 1.46.
Synapse has enriched 10 related papers. Consider them for comparative context: